Vascular Patches Market Size
Study Period | 2019 - 2029 |
Market Size (2024) | USD 406.16 Million |
Market Size (2029) | USD 616.08 Million |
CAGR (2024 - 2029) | 8.69 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Vascular Patches Market Analysis
The Vascular Patches Market size is estimated at USD 406.16 million in 2024, and is expected to reach USD 616.08 million by 2029, growing at a CAGR of 8.69% during the forecast period (2024-2029).
COVID-19 impacted the growth of the vascular patch market owing to the decreased number of vascular surgeries due to the restrictions imposed by the government to avoid the spread of coronavirus. For instance, according to an article published in Frontiers in Surgery, in August 2022, there was a 34.51% decrease in the surgical procedures reported in central Romania during a pandemic, with a disproportionate 80.6% decrease in the number of cases admitted with a diagnosis of venous insufficiency and an increase of 67.21% in the number of patients admitted with acute arterial ischemia. Also, as per the data published by the Society of Thoracic Surgeons, in April 2021, about a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases were reported in the United States. This has impacted the demand for vascular patches during the pandemic period. However, the resumed vascular surgical procedures and the high risk of developing atherosclerosis in COVID-19 patients have increased the number of surgeries performed. For instance, as per a research study published in PLOS One in April 2021, COVID-19 could increase the development of atherosclerosis due to ACE2, which is also a receptor for the Sars-CoV-2 virus. Hence, increasing COVID-19 could increase the development of atherosclerosis, which would fuel the demand for surgery. This is anticipated to increase the demand for vascular patches, which in turn is anticipated to fuel market growth in the post-pandemic era.
Over the next few years, the market is expected to grow because of things like the growing number of older people, the rise in vascular diseases, and the growing use of biological patches.
The market is also growing because people are living longer, which makes them more likely to get vascular diseases.For instance, according to an article published in the Cell Journal in May 2022, it has been observed that atherosclerosis is primarily a disease of the elderly, and most myocardial infarctions and strokes occur in the population aged 55 years or older. Also, as per an article published in Arteriosclerosis, Thrombosis, and Vascular Biology in May 2021, it has been observed that the prevalence of peripheral artery disease (PAD) is higher in women than in men. In addition, men aged 85 years or older have a higher prevalence of PAD as compared to men aged 55 to 59 years. Thus, the high burden of atherosclerosis and PAD among the aging population requires cardiac surgeries. This is likely to make more people want to use vascular patches, which will help the market grow.
Additionally, the growing burden of vascular diseases among the population is expected to increase the demand for surgeries and effective treatment, which is also contributing to market growth. According to WHO data, an estimated 1.28 billion adults worldwide aged 30-79 years had hypertension in August 2021, with the majority (two-thirds) living in low- and middle-income countries, and 46% unaware that they had the condition.Thus, a large number of people living with hypertension are at high risk of developing myocardial infarction, stroke, and peripheral vascular disease due to functional changes in blood vessels and the myocardium (left ventricular hypertrophy). This is likely to boost market growth.
The increasing number of research and development activities in the manufacturing of vascular patches is also significantly improving the growth of the market. For instance, as per an article published in the Materials Today Bio Journal in April 2022, the innovative hybrid 3D printing biotechnology has the potential for broad application in regenerative medicine and potentially in heart disease prevention. Researchers think that these kinds of studies will speed up the development of more advanced vascular patches, which will help the market grow.
Furthermore, rising company activities in developing effective vascular patches and increasing product launches are also expected to fuel market growth. For example, Terumo Corporation started a global surgical graft study called PANTHER in September 2021. This was a prospective and retrospective study of a wide range of knitted and woven surgical grafts and cardiovascular patches.
Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. But the risk of an immune response and serious complications, as well as product failures and recalls, are likely to slow the growth of the vascular patch market over the next few years.
Vascular Patches Market Trends
Aortic Aneurysms Segment Expects to Register a Significant Growth Over the Forecast Period
The aortic aneurysm segment is expected to witness significant growth in the vascular patches market over the forecast period. The factors contributing to segment growth are the rising burden of vascular diseases such as atherosclerosis, the rising geriatric population, and the growing demand for minimally invasive procedures.
Aortic aneurysms are bulges that resemble balloons in the aorta, the major artery that delivers blood from the heart through the chest and body. A pseudoaneurysm of the ascending aorta is a rare but potentially fatal complication after cardiovascular surgery, and it can result in a rupture. A small, localized saccular pseudoaneurysm of the aorta is often treated with patch repair rather than tube graft replacement.
The increasing burden of atherosclerosis and aortic aneurysm among the population is the key factor driving segment growth. For instance, according to the data published by the NHS United Kingdom in April 2022, about 1,542 aneurysms were reported in the United Kingdom in 2021.
Additionally, the increasing aging population is more likely to develop vascular diseases, which are also contributing to segment growth. For instance, the data published in October 2021 by the WHO reported that population aging is much faster than in the past. By 2030, one in six people worldwide is expected to be 60 years of age or older. Thus, the share of the population aged 60 and over is projected to increase from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. Therefore, it is anticipated that the market will grow over the forecast period due to the rising geriatric population.
Therefore, owing to the aforementioned factors, such as the increasing burden of aortic aneurysms and the rising aging population globally, the studied segment is expected to grow over the forecast period.
North America is Expected to Witness Significant Growth in the Forecast Period
North America is expected to hold a significant share of the overall vascular patch market throughout the forecast period owing to factors such as the growing prevalence of vascular diseases. In addition, healthcare expenditure is on the rise in the United States, which creates new opportunities for the innovation of advanced vascular patches and increases their availability on the market, thereby propelling market growth. According to OECD data, healthcare spending in the United States in June 2022 was 17.8% of the country's total gross domestic product (GDP) in 2021.
The increasing funding for atherosclerosis in the region is expected to accelerate the development of vascular patches and increase the company's focus on developing advanced products, hence boosting market growth. For instance, as per the data published by the NIH, in May 2022, about USD 413 million was funded for atherosclerosis 2021, and an estimated USD 430 million is allocated in 2022 for research and disease-related studies, with an expectation that this funding will reach USD 432 million by 2023.
Furthermore, the growing prevalence of cardiovascular diseases and their associated factors such as diabetes also increases the risk of developing stroke, PAD, cerebrovascular disease, and others that require surgical procedures, hence bolstering the market's growth. For instance, as per 2022 statistics published by the IDF, about 14.1 million people in Mexico were living with diabetes in 2021, and this number is projected to reach 17 million by 2030 and 21.1 million by 2045. As per the same source, about 32 million people in the United States and 2.9 million people in Canada were living with diabetes in 2021, and this number is projected to reach 36.2 million and 3.4 million by 2045, respectively. Thus, the increasing burden of diabetes may lead to a rise in cardiovascular complications, thus increasing the demand for cardiac surgeries. This is anticipated to increase the demand for effective cardiac patches, hence bolstering market growth.
Therefore, due to factors such as the rising burden of CVD and diabetes and growing funding, the studied market is expected to grow over the forecast period.
Vascular Patches Industry Overview
The vascular patch market is highly competitive and consists of several major players. the presence of major market players, such as Terumo Corporation, Baxter International, Getinge AB (Maquet), Baxter International, Inc., B. Braun SE, Edwards Lifesciences Corporation, and Becton, Dickinson, and Company, among others.
Vascular Patches Market Leaders
-
Baxter International Inc
-
Terumo Corporation
-
Edwards Lifesciences Corporation
-
Getinge AB
-
B. Braun SE
*Disclaimer: Major Players sorted in no particular order
Vascular Patches Market News
- May 2022: Vivasure Medical closed the first tranche of USD 22 million (USD 23 million) as part of its Series D financing round led by a multi-national strategic corporation. The funding supports the United States and European clinical development and regulatory approval of the company's portfolio of fully absorbable, patch-based, large-bore percutaneous vessel closure devices for transcatheter endovascular and cardiovascular procedures.
- June 2021: Axio Biosolutions received FDA approval for its hemostatic Axiostat patch, which is intended to control moderate-to-severe bleeding in vascular procedures and at the sites of surgical debridement and punctures.
Vascular Patches Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rapidly Growing Geriatric Population and Increase in the Prevalence of Vascular Diseases
- 4.2.2 Increasing Adoption of Biological Patches
-
4.3 Market Restraints
- 4.3.1 Risk of Immune Response and Serious Complications
- 4.3.2 Product Failures and Recalls
-
4.4 Industry Attractiveness - Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Material
- 5.1.1 Biologic Vascular Patches
- 5.1.2 Synthetic Vascular Patches
-
5.2 By Application
- 5.2.1 Carotid Endarterectomy
- 5.2.2 Aortic Aneurysms
- 5.2.3 Profundaplasty
- 5.2.4 Other Applications
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 United Kingdom
- 5.3.2.2 Germany
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Lemaitre Vascular
- 6.1.2 Baxter International
- 6.1.3 Getinge AB
- 6.1.4 B. Braun SE
- 6.1.5 W. L. Gore & Associates
- 6.1.6 Artivion
- 6.1.7 Edwards Lifesciences
- 6.1.8 Terumo Corporation
- 6.1.9 Vascumed (Pty) Ltd
- 6.1.10 Celox Medical
- 6.1.11 Collagen Solutions Plc
- 6.1.12 FOC Medical S.A.
- 6.1.13 Obex
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Vascular Patches Industry Segmentation
As per the scope of the report, a vascular patch is produced from polyester-urethane and is characterized by excellent biocompatibility and proven long-term mechanical stability. It is used for the closure of vascular surgery, which is preferred by several surgeons for procedures associated with the carotid, profound, roven long-term mechanical stability. It is used for the closure of vascular surgery, which is preferred by several surgeons for procedures associated with the carotid, profound, iliac, and femoral arteries. The vascular patches market is segmented by material (biologic vascular patches and synthetic vascular patches), application (carotid endarterectomy, aortic aneurysms, profundaplasty, and other applications), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
By Material | Biologic Vascular Patches | |
Synthetic Vascular Patches | ||
By Application | Carotid Endarterectomy | |
Aortic Aneurysms | ||
Profundaplasty | ||
Other Applications | ||
Geography | North America | United States |
Canada | ||
Mexico | ||
Geography | Europe | United Kingdom |
Germany | ||
France | ||
Italy | ||
Spain | ||
Rest of Europe | ||
Geography | Asia-Pacific | China |
Japan | ||
India | ||
Australia | ||
South Korea | ||
Rest of Asia-Pacific | ||
Geography | Middle East and Africa | GCC |
South Africa | ||
Rest of Middle East and Africa | ||
Geography | South America | Brazil |
Argentina | ||
Rest of South America |
Vascular Patches Market Research FAQs
How big is the Vascular Patches Market?
The Vascular Patches Market size is expected to reach USD 406.16 million in 2024 and grow at a CAGR of 8.69% to reach USD 616.08 million by 2029.
What is the current Vascular Patches Market size?
In 2024, the Vascular Patches Market size is expected to reach USD 406.16 million.
Who are the key players in Vascular Patches Market?
Baxter International Inc, Terumo Corporation, Edwards Lifesciences Corporation, Getinge AB and B. Braun SE are the major companies operating in the Vascular Patches Market.
Which is the fastest growing region in Vascular Patches Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Vascular Patches Market?
In 2024, the North America accounts for the largest market share in Vascular Patches Market.
What years does this Vascular Patches Market cover, and what was the market size in 2023?
In 2023, the Vascular Patches Market size was estimated at USD 370.86 million. The report covers the Vascular Patches Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vascular Patches Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Molecular Biosensors Industry Report
Statistics for the 2024 Europe Molecular Biosensors market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Molecular Biosensors analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.